NO964238L - Halofantrin-fri-base for behandling av malaria og blandinger - Google Patents

Halofantrin-fri-base for behandling av malaria og blandinger

Info

Publication number
NO964238L
NO964238L NO964238A NO964238A NO964238L NO 964238 L NO964238 L NO 964238L NO 964238 A NO964238 A NO 964238A NO 964238 A NO964238 A NO 964238A NO 964238 L NO964238 L NO 964238L
Authority
NO
Norway
Prior art keywords
treatment
free base
halofantrine
malaria
mixtures
Prior art date
Application number
NO964238A
Other languages
English (en)
Other versions
NO964238D0 (no
Inventor
William Neil Charman
Christopher John Hamilt Porter
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9406858A external-priority patent/GB9406858D0/en
Priority claimed from GB9416404A external-priority patent/GB9416404D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO964238D0 publication Critical patent/NO964238D0/no
Publication of NO964238L publication Critical patent/NO964238L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Anvendelse av halofantrin-fri-base ved behandling av malariainfeksjoner, spesielt lipid-baserte preparater for oral og injiserbar anvendelse.
NO964238A 1994-04-07 1996-10-04 Halofantrin-fri-base for behandling av malaria og blandinger NO964238L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9406858A GB9406858D0 (en) 1994-04-07 1994-04-07 New use and formulations
GB9416404A GB9416404D0 (en) 1994-08-13 1994-08-13 New use and formulations
PCT/EP1995/001257 WO1995027492A1 (en) 1994-04-07 1995-04-04 Halofantrine free base for the treatment of malaria and compositions

Publications (2)

Publication Number Publication Date
NO964238D0 NO964238D0 (no) 1996-10-04
NO964238L true NO964238L (no) 1996-10-04

Family

ID=26304653

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964238A NO964238L (no) 1994-04-07 1996-10-04 Halofantrin-fri-base for behandling av malaria og blandinger

Country Status (16)

Country Link
US (1) US5968987A (no)
EP (1) EP0754045B1 (no)
JP (1) JPH09512794A (no)
CN (1) CN1145030A (no)
AT (1) ATE213937T1 (no)
AU (1) AU685263B2 (no)
BR (1) BR9507437A (no)
CA (1) CA2187185A1 (no)
CZ (1) CZ293696A3 (no)
DE (1) DE69525740T2 (no)
ES (1) ES2170143T3 (no)
HU (1) HUT76051A (no)
NO (1) NO964238L (no)
NZ (1) NZ284068A (no)
PL (1) PL179608B1 (no)
WO (1) WO1995027492A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5340298A (en) * 1996-12-27 1998-07-31 Takeda Chemical Industries Ltd. Stabilized tricyclic compound
US6979456B1 (en) * 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
IN191696B (no) * 1999-02-12 2003-12-20 Council Scient Ind Res
US6616942B1 (en) * 1999-03-29 2003-09-09 Soft Gel Technologies, Inc. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
US6759058B1 (en) * 2001-04-25 2004-07-06 Western Center For Drug Development College Of Pharmacy Western University Of Health Sciences Enteric-coated proliposomal formulations for poorly water soluble drugs
AUPR573001A0 (en) * 2001-06-15 2001-07-12 Glaxo Wellcome Australia Ltd Lymphatic drug delivery system
WO2003041632A2 (en) 2001-11-14 2003-05-22 Texas Tech University Eutectic-based self-nanoemulsified drug delivery system
US20060148776A1 (en) * 2003-03-13 2006-07-06 Conforma Therapeutics Corporation Drug formulations having long and medium chain triglycerides
AU2004277951B2 (en) 2003-09-29 2010-11-11 Soft Gel Technologies, Inc. Solubilized CoQ-10
US8124072B2 (en) 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
US20050220866A1 (en) * 2004-04-02 2005-10-06 Dr. Reddy's Laboratories Limited Novel capsule formulations of etoposide for oral use
US8343541B2 (en) 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions
SA109300195B1 (ar) 2008-03-28 2013-04-20 Astrazeneca Ab تركيبة صيدلانية جديدة مضادة للسرطان
CA2690490C (en) * 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
US9309136B2 (en) * 2014-06-12 2016-04-12 Tersus Environmental, Llc Bioremediation of soil and groundwater
MX2016016173A (es) * 2014-06-19 2017-03-28 Solural Pharma ApS Forma de dosis oral solida de compuestos lipofilicos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507288A (en) * 1983-09-16 1985-03-26 Smithkline Beckman Corporation β-Glycerophosphate salts of antimalarial phenanthrenemethanol compounds
US4818767A (en) * 1983-11-02 1989-04-04 Smithkline Beckman Corporation Quinate salts of antimalarial phenanthrenemethanol compounds
US5278173A (en) * 1988-06-30 1994-01-11 Davis Michael H Method of inhibiting the activity of human immunodeficiency virus (HIV) in vivo
AP9200405A0 (en) * 1991-07-15 1994-01-13 Smithkline Beecham Ag Pharmaceutical formulations comprised of micronised halofantrine.

Also Published As

Publication number Publication date
EP0754045B1 (en) 2002-03-06
NO964238D0 (no) 1996-10-04
CA2187185A1 (en) 1995-10-19
HU9602740D0 (en) 1996-11-28
CZ293696A3 (en) 1997-01-15
PL179608B1 (pl) 2000-10-31
CN1145030A (zh) 1997-03-12
DE69525740D1 (de) 2002-04-11
NZ284068A (en) 1998-06-26
AU685263B2 (en) 1998-01-15
MX9604611A (es) 1997-11-29
ES2170143T3 (es) 2002-08-01
DE69525740T2 (de) 2002-10-24
HUT76051A (en) 1997-06-30
JPH09512794A (ja) 1997-12-22
BR9507437A (pt) 1997-09-16
ATE213937T1 (de) 2002-03-15
US5968987A (en) 1999-10-19
AU2256895A (en) 1995-10-30
WO1995027492A1 (en) 1995-10-19
EP0754045A1 (en) 1997-01-22
PL316656A1 (en) 1997-02-03

Similar Documents

Publication Publication Date Title
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
NO964238D0 (no) Halofantrin-fri-base for behandling av malaria og blandinger
NO302366B1 (no) 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat
NO307968B1 (no) Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav
DE60110342T8 (de) Alpha-Interferon enthaltende Hautpflegemittel
ATE264863T1 (de) 28-epirapaloge
BG101132A (en) Pyridoanilated thienyl and furanyl oxazolidinons
TR200200068T2 (tr) Nematisital triflüorobütenler
SE9802729D0 (sv) Novel Compounds
DK0975333T3 (da) Alginatgel med langvarig frigörelse
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
YU58599A (sh) Gelovi sa usporenim podržanim oslobađanjem
ES2162110T3 (es) Derivados de la quinolina antimalaria.
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
NO970573L (no) Ylidenforbindelser og deres fremstilling
BG103543A (en) The use of pramipexol in the treatment of the uneasy legs syndrome
DK0656889T3 (da) 9-chlorprostaglandinestere og -amider og deres anvendelse ved fremstilling af lægemidler
NO20005548L (no) Mykobakterieinhibitorer
ATE361757T1 (de) Stabile fumagillin-formulierung
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase
NO20021429L (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
DE50211461D1 (de) Pharmazeutische zusammensetzung enthaltend bulbophyllum
ITBS940003V0 (it) Lettino prendisole utilizzabile anche come poltrona

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application